BCR and cancer: The first citation of data from the T1D TCR/BCR Repository has just been published, where data from the type 1 diabetes study from Seay et al [55] (loaded into the repository in March 2023) was reused in a recent cancer study from Sammut et al [76] that explored BCR clonal centrality in immunosurveillance across cancer, type 1 diabetes and multiple sclerosis.